These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 27903976)
21. The prognostic value of Cyclin B1 in pancreatic cancer. Zhou L; Li J; Zhao YP; Cui QC; Zhou WX; Guo JC; You L; Wu WM; Zhang TP Med Oncol; 2014 Sep; 31(9):107. PubMed ID: 25106528 [TBL] [Abstract][Full Text] [Related]
22. The prognostic value of HOXA13 in solid tumors: A meta-analysis. Wen Y; Shu F; Chen Y; Chen Y; Lan Y; Duan X; Zhao SC; Zeng G Clin Chim Acta; 2018 Aug; 483():64-68. PubMed ID: 29678634 [TBL] [Abstract][Full Text] [Related]
23. Prognostic value of Zinc-finger protein X-linked in patients with solid tumors. Dai C; Dong Q; Lu Q; Liu FT; Zhu ZM Minerva Chir; 2017 Feb; 72(1):81-88. PubMed ID: 27733754 [TBL] [Abstract][Full Text] [Related]
24. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis. Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435 [TBL] [Abstract][Full Text] [Related]
25. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis. Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication. Begnami MD; Fregnani JH; Nonogaki S; Soares FA Hum Pathol; 2010 Aug; 41(8):1120-7. PubMed ID: 20334896 [TBL] [Abstract][Full Text] [Related]
27. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer. Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764 [TBL] [Abstract][Full Text] [Related]
29. Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis. Chen S; He H; Wang Y; Liu L; Liu Y; You H; Dong Y; Lyu J BMC Cancer; 2018 Aug; 18(1):838. PubMed ID: 30126359 [TBL] [Abstract][Full Text] [Related]
30. The prognostic value of cyclin D1 expression in the survival of cancer patients: A meta-analysis. Moradi Binabaj M; Bahrami A; Khazaei M; Ryzhikov M; Ferns GA; Avan A; Mahdi Hassanian S Gene; 2020 Feb; 728():144283. PubMed ID: 31838249 [TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of microRNA-101 in solid tumor: A meta-analysis. Ma X; Bai J; Xie G; Liu Y; Shuai X; Tao K PLoS One; 2017; 12(7):e0180173. PubMed ID: 28742860 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis. Kang J; Jung H; Kim H Medicine (Baltimore); 2024 Jan; 103(3):e37016. PubMed ID: 38241547 [TBL] [Abstract][Full Text] [Related]
33. Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1. Dong XL; Xu PF; Miao C; Fu ZY; Li QP; Tang PY; Wang T Biomed Pharmacother; 2012 Feb; 66(1):70-5. PubMed ID: 22264882 [TBL] [Abstract][Full Text] [Related]
34. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis. Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852 [TBL] [Abstract][Full Text] [Related]
35. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma. Obermann EC; Went P; Pehrs AC; Tzankov A; Wild PJ; Pileri S; Hofstaedter F; Dirnhofer S Oncol Rep; 2005 Dec; 14(6):1461-7. PubMed ID: 16273239 [TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis. Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926 [TBL] [Abstract][Full Text] [Related]
37. EIF3D silencing suppresses renal cell carcinoma tumorigenesis via inducing G2/M arrest through downregulation of Cyclin B1/CDK1 signaling. Pan XW; Chen L; Hong Y; Xu DF; Liu X; Li L; Huang Y; Cui LM; Gan SS; Yang QW; Huang H; Qu FJ; Ye JQ; Wang LH; Cui XG Int J Oncol; 2016 Jun; 48(6):2580-90. PubMed ID: 27035563 [TBL] [Abstract][Full Text] [Related]
38. Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function. De Giorgi U; Yuan J; Moroni M; Veronese S; Sartore-Bianchi A; Broggini M; Rosti G; Strebhardt K; Ruffini PA Int J Biol Markers; 2015 Jul; 30(3):e275-81. PubMed ID: 25982682 [TBL] [Abstract][Full Text] [Related]
39. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene. Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040 [TBL] [Abstract][Full Text] [Related]
40. [The evaluation of prognostic value of cyclin B1 expression in patients with resected non-small-cell lung cancer stage I-IIIA--preliminary report]. Kosacka M; Korzeniewska A; Jankowska R Pol Merkur Lekarski; 2010 Feb; 28(164):117-21. PubMed ID: 20369739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]